Molecular imaging plays a vital role in current medical diagnostics. There is a constant need for new and improved molecular imaging agents in terms of resolution, specificity, stability, safety... Show moreMolecular imaging plays a vital role in current medical diagnostics. There is a constant need for new and improved molecular imaging agents in terms of resolution, specificity, stability, safety and cost. The research described in this thesis deals with the development of activatable luminescence lifetime imaging agents as well as with the use of supramolecular chemistry to introduce cell surface modifications to living cells. Show less
Glioblastoma multiforme (GBM) is the most malignant variant of glioma. This tumor does not only display an extremely aggressive, invasive growth pattern, but is also very difficult to treat. With a... Show moreGlioblastoma multiforme (GBM) is the most malignant variant of glioma. This tumor does not only display an extremely aggressive, invasive growth pattern, but is also very difficult to treat. With a two-year survival rate of 40% and a median survival of 12-18 months after treatment, prognosis is poor. Current treatment options are not successful in halting tumor progression and GBM tumors are highly heterogeneous, display all kinds of anti-apoptotic escape routes, suppress the immune system, invade the surrounding parenchyma with unmatched aggressiveness and possess a whole array of tools to rearrange the extra tumoral environment to their advantage. The aim of this thesis is to combine the strengths of gene-therapy and bioluminescence Imaging (BLI) for the development of novel reporter systems in order to study glioma tumor biology and its response to therapeutic compounds. We optimized the currently available BLI luciferases (Gaussia luciferase, Vargula hilgendorfi) and assays (Gluc blood assay, Mycoplasma detection assay). We explored a new multimodal targeted liposome formulation with increased relaxivity for the treatment and imaging of cancer. Finally we combined the newly developed and enhanced reporters to test a new therapeutic combination for the treatment of Glioma (TRAIL, Lanatoside C). Show less
In pre-clinical research, whole-body small-animal imaging is widely used for in vivo visualization of functional and anatomical information to study cancer, neurological and cardiovascular diseases... Show moreIn pre-clinical research, whole-body small-animal imaging is widely used for in vivo visualization of functional and anatomical information to study cancer, neurological and cardiovascular diseases and help with a faster development of new drugs. Functional information is provided by imaging modalities such as PET, SPECT and specialized MRI. Structural imaging modalities like CT, MRI and ultrasound provide detailed depictions of anatomy. Optical imaging modalities, such as BLI and near-infrared-fluorescence offer a high sensitivity in visualizing molecular processes in vivo. Combining these modalities enables to follow the subject(s) and molecular processes in time, in living animals. With these advances in image acquisition, the problem has shifted from data acquisition to data processing: organization, analysis and interpretation of this heterogeneous whole-body imaging data has become a demanding task. Here, our data processing approach is based on an articulated whole-body atlas as a common reference to normalize the geometric heterogeneity caused by postural and anatomical differences between individuals and geometric differences between imaging modalities. Mapping to this atlas has the advantage that all the different imaging modalities can be registered to a common anatomical reference; postural variations can be corrected, and the different animals can be scaled properly while allowing for proper management of this high-throughput data. Show less
The aim of this work was to develop methods to measure structural changes in the skeleton using MicroCT. In addition, these new methods should be able to quantify biologically relevant changes. In... Show moreThe aim of this work was to develop methods to measure structural changes in the skeleton using MicroCT. In addition, these new methods should be able to quantify biologically relevant changes. In order to do this, normalized methods to analyse MicroCT scans and perform quantitative measurements within these datasets are described in this thesis. These techniques were combined with a biological angiogenesis assay and used as research tools in a study comparing various different combination treatments of bone metastases. Show less
Stem cell therapy has raised enthusiasm as a potential treatment for cardiovascular diseases. However, questions remain about the in vivo behavior of the cells after transplantation and the... Show moreStem cell therapy has raised enthusiasm as a potential treatment for cardiovascular diseases. However, questions remain about the in vivo behavior of the cells after transplantation and the mechanism of action with which the cells could potentially alleviate disease symptoms. The objective of the research as described in this thesis was to visualize survival, proliferation, and migration of embryonic (ESC) and adult stem cells using non-invasive molecular imaging techniques in small animal models of cardiovascular diseases. The major findings can be described as follows: (1) Non-invasive bioluminescence imaging is a validated tool to monitor donor cell survival, proliferation, migration, and misbehavior; (2) ESC are a potential source for true regenerative therapy; (3) ESC form teratomas; (4) Adult stem cell survival is short-lived, but of all cells currently used in the clinic, mononuclear cells show the most prolonged survival; (5) Transplantation of mononuclear cells can preserve cardiac function in the short term after myocardial infarction in mice; (6) Compared to other measurements of murine cardiac function, Micro-CT is a superior method to assess cardiac geometry and function; and (7) Transplantation of mononuclear cells in peripheral artery disease is hampered by dismal cell survival and homing. These findings illustrate the current challenges for optimizing stem cell therapy for cardiovascular disease. Show less
Given their self-renewing and pluripotent capabilities, embryonic stem cells (ESCs) are well-poised as a cellular source for tissue regeneration therapy. Successful in vitro differentiation of both... Show moreGiven their self-renewing and pluripotent capabilities, embryonic stem cells (ESCs) are well-poised as a cellular source for tissue regeneration therapy. Successful in vitro differentiation of both mouse (m) and human (h) ESCs into multiple somatic cell types has been reported, including cardiomyocytes, neurons and pancreatic islet cells. However, the host immune response against transplanted ESCs is not well characterized. In fact, controversy remains as to whether ESCs have immune-privileged properties. The scope of the current thesis is to gain insight into immunological aspects of transplantation of embryonic stem cells or their differentiated progeny by using molecular imaging techniques to follow cell fate. Specifically, this thesis presents evidence that: (1) molecular imaging can be used to quantify organ and ESC survival following transplantation and non-invasively follow donor graft fate; (2) ESCs express MHC and co-signaling molecules that are upregulated upon differentiation; (3) mESCs and hESCs can trigger potent cellular and humoral immune responses following allogeneic and/or xenogeneic transplantation, leading to rejection; and (4) immunosuppressive drugs can significantly mitigate the host immune response to prolong hESC survival in immunocompetent mice. These results clearly indicate that ESC immunogenicity is a significant hurdle that must be overcome before successful clinical application can be accomplished. Show less
![Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [F-18]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumour](/sites/all/modules/custom/islandora_solr_search/images/defaultimg.png?solr_nav%5Bid%5D=98ee0a1e70a4ab5701b4&solr_nav%5Bpage%5D=1&solr_nav%5Boffset%5D=9)
